EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Micrococcus spp. as a promising source for drug discovery: A review

Daniela Tizabi, Russell T Hill iD

Journal of Industrial Microbiology and Biotechnology · 17.02.2023 · 50 (1)

DOI: 10.1093/jimb/kuad017 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Industrial Microbiology and Biotechnology, online erschienen am 17.07.2023. Verfasst von Daniela Tizabi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Marine and Environmental Technology, University of Maryland Center for Environmental Science, Baltimore, MD 21202, USA. Hauptthemen laut MEDLINE: Micrococcus, Actinobacteria. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIST DOC, University of Maryland, National Institute of Standards and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Historically, bacteria of the phylum, Actinobacteria have been a very prominent source of bioactive compounds for drug discovery. Among the actinobacterial genera, Micrococcus has not generally been prioritized in the search for novel drugs. The bacteria in this genus are known to have very small genomes (generally < 3 Mb). Actinobacteria with small genomes seldom contain the well-characterized biosynthetic gene clusters such as those encoding polyketide synthases and nonribosomal peptide synthetases that current genome mining algorithms are optimized to detect. Nevertheless, there are many reports of substantial pharmaceutically relevant bioactivity of Micrococcus extracts. On the other hand, there are remarkably few descriptions of fully characterized and structurally elucidated bioactive compounds from Micrococcus spp. This review provides a comprehensive summary of the bioactivity of Micrococcus spp. that encompasses antibacterial, antifungal, cytotoxic, antioxidant, and anti-inflammatory activities. This review uncovers the considerable biosynthetic potential of this genus and highlights the need for a re-examination of these bioactive strains, with a particular emphasis on marine isolates, because of their potent bioactivity and high potential for encoding unique molecular scaffolds.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicrococcusActinobacteriaBacteriaAnti-Bacterial AgentsPolyketide SynthasesDrug Discovery

Stichwörter der Autor:innen

MicrococcusActinomycete natural productsDrug discovery

Substanzen

Anti-Bacterial AgentsPolyketide Synthases

Autor:innen und Institutionen

  • Institute of Marine and Environmental Technology, University of Maryland Center for Environmental Science, Baltimore, MD 21202, USA.

ORCID-Profile: Russell T Hill

Förderung

  • NIST DOC
  • University of Maryland
  • National Institute of Standards and Technology

Zitieren

APA

Tizabi, D., & Hill, R. T. (2023). Micrococcus spp. as a promising source for drug discovery: A review. Journal of Industrial Microbiology and Biotechnology, 50(1). https://doi.org/10.1093/jimb/kuad017

Vancouver

Tizabi D, Hill RT. Micrococcus spp. as a promising source for drug discovery: A review. Journal of Industrial Microbiology and Biotechnology. 2023;50(1). doi:10.1093/jimb/kuad017

BibTeX
@article{Tizabi2023,
  author = {Tizabi, Daniela and Hill, Russell T},
  title = {Micrococcus spp. as a promising source for drug discovery: A review},
  journal = {Journal of Industrial Microbiology and Biotechnology},
  year = {2023},
  volume = {50},
  number = {1},
  doi = {10.1093/jimb/kuad017}
}
Kostenlos starten →